Linda C Laux

  • 1783 Citations
20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

My clinical and research focus is epilepsy syndromes, genetics of epilepsy syndromes, and Dravet syndrome.

Certifications and Licenses

Clinical Neurophysiology
Child Neurology

Training Experience

1993Residency, University of Arizona Health Science Center
1997Fellowship, Saint Joseph's Hospital, Phoenix
2001Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)

Education/Academic qualification

MD, Saint Louis University

… → 1990

Research interests

  • EEG
  • Epigenetics
  • Epilepsy
  • Pediatric Neurology

Fingerprint Dive into the research topics where Linda C Laux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

  • 1783 Citations
  • 27 Article
  • 1 Comment/debate
  • 1 Letter

A single-center, retrospective analysis of genotype-phenotype correlations in children with Dravet syndrome

Gertler, T. S., Calhoun, J. & Laux, L., Feb 2020, In : Seizure. 75, p. 1-6 6 p.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    Fenfluramine for Treatment-Resistant Seizures in Patients with Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial

    Nabbout, R., Mistry, A., Zuberi, S., Villeneuve, N., Gil-Nagel, A., Sanchez-Carpintero, R., Stephani, U., Laux, L., Wirrell, E., Knupp, K., Chiron, C., Farfel, G., Galer, B. S., Morrison, G., Lock, M., Agarwal, A. & Auvin, S., Mar 2020, In : JAMA Neurology. 77, 3, p. 300-308 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 8 Scopus citations

    Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

    FAiRE DS Study Group, Dec 21 2019, In : The Lancet. 394, 10216, p. 2243-2254 12 p.

    Research output: Contribution to journalArticle

  • 12 Scopus citations

    Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial

    Devinsky, O., Nabbout, R., Miller, I., Laux, L. C., Zolnowska, M., Wright, S. & Roberts, C., Feb 1 2019, In : Epilepsia. 60, 2, p. 294-302 9 p.

    Research output: Contribution to journalArticle

  • 35 Scopus citations

    Long-term safety and efficacy of cannabidiol in children and adults with treatmentresistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results

    Laux, L. C., Bebin, E. M., Checketts, D., Chez, M., Flamini, R., Marsh, E. D., Miller, I., Nichol, K., Park, Y., Segal, E., Seltzer, L., Szaflarski, J. P., Thiele, E. A. & Weinstock, A., Aug 2019, In : Epilepsy Research. 154, p. 13-20 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • 22 Scopus citations